CGS vs IIQ

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

57MEDIUM

IIQ

INOVIQ LTD FPO [IIQ]

56MEDIUM

Score Breakdown

CGS IIQ
Technical
61
58
Catalyst
55
54
Sentiment
50
50
Fundamental
99
91
Momentum
64
39
Risk Gate
45
50

Key Metrics

CGS Metric IIQ
$523.4MMarket Cap$26.7M
699KAvg Volume (20d)111K
+0.0%Short InterestN/A
$3.23052-Week High$0.565
$1.69052-Week Low$0.165
-0.3%Daily Change+5.7%
$3.070Reference Price$0.185
+22.5%ROE-42.2%
+19.5%Profit MarginN/A

Active Signals

CGS Signals

●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.6x)
●Moderate revenue growth (+16%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week high (90% of range)

IIQ Signals

●MACD momentum is picking up steam
●Above-average volume (1.8x) on a green day — buyers stepping up
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (6 quarters)
●Moderate P/S ratio (12.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (6% of range)

Ask Scout AI to compare CGS and IIQ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CGS vs LDX →CGS vs LGP →EYE vs SOM →NOX vs RHT →LDX vs SPL →
CGS Full Analysis → IIQ Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).